AJP - Gastrointestinal and Liver Physiology, Vol 258, Issue 2 253-G260, Copyright © 1990 by American Physiological Society

ARTICLES

Characterization of the major form of cholecystokinin in human intestine: CCK-58

V. E. Eysselein, G. A. Eberlein, M. Schaeffer, D. Grandt, H. Goebell, W. Niebel, G. L. Rosenquist, H. E. Meyer and J. R. Reeve Jr
Harbor-University of California, Los Angeles, Department of Gastroenterology, Torrance 90502.

Acid extracts of human intestines obtained from surgical samples or from organ donors contain cholecystokinin (CCK) immunoreactivity. From surgical samples, extracted and eluted quickly, greater than 75% of the CCK immunoreactivity eluted in the same region as purified canine CCK-58 during analytical reverse-phase high-pressure liquid chromatography (HPLC). A major portion of the CCK immunoreactivity from donor intestinal extracts also eluted in this region. This immunoreactivity has been purified from human intestinal extracts by a series of several reverse-phase and cation-exchange chromatographies. Amino acid and microsequence analysis showed that this immunoreactivity is human CCK-58. Tryptic digestion of purified human CCK-58 produced another immunoreactive form that eluted in the position of CCK-8 during analytical reverse-phase HPLC. The immunoreactivity of the trypsin-digested material was 2.6-fold higher than that of an identical sample of CCK-58 incubated without trypsin. Thus the carboxyl-terminal antibody used for radioimmunoassay cross-reacts greater than twofold less with human CCK-58. This diminished cross-reactivity would lead to an underestimation of the relative proportions of CCK-58 in tissue and plasma extracts. If CCK-58 is the major circulating form this diminished cross-reactivity would also lead to underestimations of the circulating levels of total CCK. Determination of human CCK-58 structure confirms that one of the major components of human CCK that expresses biological activity is CCK-58.

This article has been cited by other articles:

				J. R. Reeve Jr., R. A. Liddle, D. C. McVey, S. R. Vigna, T. E. Solomon, D. A. Keire, G. Rosenquist, J. E. Shively, T. D. Lee, P. Chew, et al. Identification of nonsulfated cholecystokinin-58 in canine intestinal extracts and its biological properties Am J Physiol Gastrointest Liver Physiol, August 1, 2004; 287(2): G326 - G333. [Abstract] [Full Text] [PDF]

				J. R. Reeve Jr, G. M. Green, P. Chew, V. E. Eysselein, and D. A. Keire CCK-58 is the only detectable endocrine form of cholecystokinin in rat Am J Physiol Gastrointest Liver Physiol, July 7, 2003; 285(2): G255 - G265. [Abstract] [Full Text] [PDF]

				S. M. Simasko, J. Wiens, A. Karpiel, M. Covasa, and R. C. Ritter Cholecystokinin increases cytosolic calcium in a subpopulation of cultured vagal afferent neurons Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2002; 283(6): R1303 - R1313. [Abstract] [Full Text] [PDF]

				R. A. Liddle On the Measurement of Cholecystokinin Clin. Chem., May 1, 1998; 44(5): 903 - 904. [Full Text] [PDF]